Inventor
HOLLOWAY M KATHARINE
US17 patents
⚠️ This page may combine multiple inventors who share the name “HOLLOWAY M KATHARINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
8 patentsUS7470664B2Dec 30, 2008
HCV NS3 protease inhibitors
MERCK & CO INC81 citations97
US5413999AMay 9, 1995
HIV protease inhibitors useful for the treatment of AIDS
MERCK & CO INC247 citations97
US5846978ADec 8, 1998
HIV protease inhibitors useful for the treatment of AIDS
MERCK & CO INC29 citations91
US5607967AMar 4, 1997
Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
MERCK & CO INC36 citations91
US5679518AOct 21, 1997
Method for finding transcription activators of the NER steroid hormone receptor
MERCK & CO INC8 citations72
US5668132ASep 16, 1997
HIV Protease inhibitors useful for the treatment of AIDS
MERCK & CO INC6 citations72
US5527799AJun 18, 1996
HIV protease inhibitors useful for the treatment of AIDS
MERCK & CO INC11 citations72
US5717097AFeb 10, 1998
HIV protease inhibitors useful for the treatment of AIDS
MERCK & CO INC5 citations62
MERCK SHARP & DOHME
4 patentsUS7879797B2Feb 1, 2011
HCV NS3 protease inhibitors
MERCK SHARP & DOHME15 citations84
US10138255B2Nov 27, 2018
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations50
US9840478B2Dec 12, 2017
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations48
US7932275B2Apr 26, 2011
2-aminopyridine compounds useful as β-secretase inhibitors for the treatment of alzheimer's disease
MERCK SHARP & DOHME0 citations41